Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > I mean accelerated approval... not fast track
View:
Post by SundayMovies on Jun 05, 2023 4:25pm

I mean accelerated approval... not fast track

They got fast track already.

PFS will help make the trial faster as OS can take forever if the drug works. Oddly, OS means how long you will live on.

OS would not be faire.

PFS  will suffice for approval with FDA.
Comment by Buckhenry on Jun 05, 2023 5:04pm
No matter how much cologne  you put on doggie  do... it still stinks. 
Comment by Azzak34 on Jun 05, 2023 5:18pm
You should try different cologne, Hugo is pretty strong. 
Comment by Buckhenry on Jun 05, 2023 7:48pm
Assak  don't water down oncy with that cheap Hugo cologne. I would go all out with a very high cologne  like brut 33 or go very high end with old spice. 
Comment by inthno on Jun 05, 2023 5:07pm
You may be right as pfs may suffice but that is why I am thinking the 2 Co endpoints for the trial because if pfs does not come through then we are still good with os as the primary endpoint. As for AA, hard to say if that will happen as the now standard of care is difficult to compete with although anything is possible. As the kol panel did state, there is still room for improvement.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities